Concord Drugs Ltd vs Torrent Pharmaceuticals Limited

A side-by-side comparison of Concord Drugs Ltd (CONCORDDRUGSLTD) and Torrent Pharmaceuticals Limited (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Torrent Pharmaceuticals Limited leads CONCORDDRUGSLTD vs TORNTPHARM on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth11
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

51.90
P/E ratio
71.32
2.20
P/B ratio
22.29
0.00%
Dividend yield
0.77%
₹0.30
EPS
₹63.92

Profitability

TORNTPHARM takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

2.52%
Return on equity
25.78%
4.73%
Return on capital
13.91%
10.21%
EBITDA margin
32.61%
0.81%
Net margin
15.29%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

15.34%
Revenue CAGR (3Y)
13.27%
5.67%
Profit CAGR (3Y)
19.75%

Size & financial health

TORNTPHARM takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹105 Cr
Market cap
₹1.73L Cr
₹37 Cr
Revenue
₹13,980 Cr
₹0 Cr
Net profit
₹2,138 Cr
0.24
Debt / equity
1.79
Concord Drugs Ltd
  • + ["Company has reduced debt.", "Company is expected to give good quarter"]
  • − ["Though the company is reporting repeated profits, it is not paying out dividend", "Promoter holding has decreased over last quarter: -9.31%", "The company has delivered a poor sales growth of 8.13% over past five years.", "Company has a low return on equity of 1.63% over last 3 years."]
Torrent Pharmaceuticals Limited
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 67.6%"]
  • − ["Stock is trading at 20.67 times its book value", "Company has a high debt to equity ratio of 1.79."]
Concord Drugs Ltd full analysis Torrent Pharmaceuticals Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

CONCORDDRUGSLTD vs TORNTPHARM: Share Price, Valuation & Which to Buy | DocStoX